Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,894 | 4,511 | 3,199 | 7,042 | 9,184 |
| Receivables | N/A | N/A | N/A | N/A | 818 |
| TOTAL | $7,942 | $4,557 | $3,246 | $7,088 | $10,060 |
| Non-Current Assets | |||||
| PPE Net | 1 | 1 | 1 | 1 | 2 |
| Investments And Advances | 57 | 0 | 2 | 2 | 2 |
| Intangibles | 9,347 | 1,587 | 1,587 | 1,587 | 1,587 |
| Other Non-Current Assets | 19,400 | 19,400 | 19,400 | 19,400 | 19,400 |
| TOTAL | $28,805 | $20,988 | $20,990 | $20,990 | $20,991 |
| Total Assets | $36,746 | $25,545 | $24,236 | $28,078 | $31,051 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,714 | 2,431 | 1,926 | 2,083 | 1,573 |
| Accrued Expenses | 1,721 | 1,434 | 1,262 | 1,644 | 1,438 |
| TOTAL | $4,608 | $4,038 | $3,361 | $3,900 | $3,185 |
| Non-Current Liabilities | |||||
| TOTAL | $4,986 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,594 | $4,038 | $3,361 | $3,900 | $3,185 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,157 | 883 | 883 | 741 | 712 |
| Common Shares | 29 | 22 | 19 | 18 | 16 |
| Retained earnings | -53,046 | -52,170 | -47,765 | -44,133 | -40,258 |
| TOTAL | $27,153 | $21,507 | $20,875 | $24,178 | $27,866 |
| Total Liabilities And Equity | $36,746 | $25,545 | $24,236 | $28,078 | $31,051 |